Working… Menu

Study to Evaluate the Safety and Efficacy of ATYR1923 In Patients With Severe Pneumonia Related to COVID-19

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04412668
Recruitment Status : Completed
First Posted : June 2, 2020
Last Update Posted : January 29, 2021
Information provided by (Responsible Party):
aTyr Pharma, Inc.

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : December 21, 2020
Actual Study Completion Date : December 21, 2020